The Effect of Quadratus Lumborum (QL) Block on the Incidence of Chronic Neuropathic Pain After Retroperitoneal Laparoscopic Donor Nephrectomy: A Study on Neuroinflammation and Neurophysiology

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorIndonesia University

About this trial

To analyze the relationship of anterior subcostal quadratus lumborum (QL) block compared with control block on the incidence of chronic neuropathic pain at three months post-laparoscopic retroperitoneal living kidney donor.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

The patient was known to have a history of chronic non-cancer pain and cancer pain.

Trial design

Design model

Parallel

Treatments tested in this trial

  • injection of local anesthesia solution

    Drug

    Injection of 30 mL local anesthetic solution bupivacaine 0.25%

  • Injection of normal saline

    Drug

    Injection of 30 mL normal saline Natrium Chloride (NaCl) 0.9%

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Quadratus Lumborum BlockExperimental treatment 1 intervention
Group B: Quadratus Lumborum Sham BlockPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Neuropathic Pain Incidence: Neuropathic Pain in 4 Questionnaire

Pain that develops after a surgical procedure in the area of surgery and its radiation, persists for at least 3 months after surgery, other causes of pain (e.g. infection and history of malignancy) or pre-existing pain have been excluded. Total score: 10 Score ≤ 4 = no pain developed Score ≥ 4 = pain developed

Time frame
3 months after intervention
2

Neuromodulation Parameter: Degree of functional interference using Behavioral Pain Interference (BPI)

The degree of pain that develops after a surgical procedure in the area of surgery and its radiation, persisting for at least 3 months after surgery, other causes of pain (eg infection and history of malignancy) or pre-existing pain have been excluded. Behavioral Pain Interference (BPI) questionnaire based on the average of questions 4, 5, and 6 1. Mild (NRS 1-3) 2. Moderate (NRS 4-6) 3. Severe (NRS 7-10)

Time frame
At 3 months after intervention
3

Chronic Pain Severity: Leeds Assesment of neuropathic symptoms and sign (LANSS) scale

A measuring tool used to assess neuropathic pain and provides information to differentiate nociceptive pain from neuropathic pain. Total score: 24 \<12: Not neuropathic \>12: Neuropathic pain

Time frame
At 3 months after intervention
4

Neuroinflammation Parameter: Serum Concentration of Toll-like Receptor 4 (TLR4)

Transmembrane receptors in the innate immune system. Units: ng/mL

Time frame
At 3 months after intervention

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: